Company Transgenomic Inc Nasdaq
Equities
US89365K3059
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
04-19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
04-01 | Transcript : Precipio, Inc. - Special Call |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Service
80.1
%
| 8 | 89.4 % | 12 | 80.1 % | +44.67% |
Other
19.9
%
| 1 | 14.9 % | 3 | 19.9 % | +115.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 15 | 100.0 % | +61.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Ahmed Zaki Sabet
COO | Chief Operating Officer | 68 | 18-08-06 |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 80 | 19-12-02 |
Director/Board Member | - | 12-31 | |
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Jeffrey Cossman
BRD | Director/Board Member | 77 | 17-09-25 |
David Cohen
BRD | Director/Board Member | 65 | 17-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,469,540 | 1,406,273 ( 95.69 %) | 0 | 95.69 % |
Stock B | 0 | 47 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-16.33% | 18.83B | |
-42.18% | 2.92B | |
+22.02% | 1.9B | |
+0.39% | 1.71B | |
+27.15% | 1.26B | |
-10.70% | 1.04B | |
-18.27% | 961M | |
+0.66% | 779M | |
-25.07% | 649M |
- Stock Market
- Equities
- PRPO Stock
- Stock
- Company Transgenomic Inc